BioSig Statistics

Share Statistics

BioSig has 31.33M shares outstanding. The number of shares has increased by 67.67% in one year.

Shares Outstanding	31.33M
Shares Change (YoY)	67.67%
Shares Change (QoQ)	18.46%
Owned by Institutions (%)	5.05%
Shares Floating	19.08M
Failed to Deliver (FTD) Shares	69
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 1.83M, so 5.18% of the outstanding shares have been sold short.

Short Interest	1.83M
Short % of Shares Out	5.18%
Short % of Float	6.17%
Short Ratio (days to cover)	2.26

Valuation Ratios

The PE ratio is -20.25 and the forward PE ratio is -22.82. BioSig's PEG ratio is 0.25.

PE Ratio	-20.25
Forward PE	-22.82
PS Ratio	5230.55
Forward PS	2.2
PB Ratio	-145.39
P/FCF Ratio	-43.97
PEG Ratio	0.25

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioSig.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.15, with a Debt / Equity ratio of -0.07.

Current Ratio	0.15
Quick Ratio	0.15
Debt / Equity	-0.07
Debt / EBITDA	-0.01
Debt / FCF	-0.02
Interest Coverage	-1169.27

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$8K
Profits Per Employee	$-2.07M
Employee Count	5
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 817.41% in the last 52 weeks. The beta is 1.82, so BioSig's price volatility has been higher than the market average.

Beta	1.82
52-Week Price Change	817.41%
50-Day Moving Average	5.34
200-Day Moving Average	2.89
Relative Strength Index (RSI)	40.85
Average Volume (20 Days)	1,085,219

Income Statement

In the last 12 months, BioSig had revenue of 40K and earned -10.33M in profits. Earnings per share was -0.07.

Revenue	40K
Gross Profit	40K
Operating Income	-12.86M
Net Income	-10.33M
EBITDA	-12.42M
EBIT	-12.61M
Earnings Per Share (EPS)	-0.07

Full Income Statement

Balance Sheet

The company has 142K in cash and 102K in debt, giving a net cash position of 40K.

Cash & Cash Equivalents	142K
Total Debt	102K
Net Cash	40K
Retained Earnings	-255.34M
Total Assets	109.72M
Working Capital	-110.2M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.76M and capital expenditures 0, giving a free cash flow of -4.76M.

Operating Cash Flow	-4.76M
Capital Expenditures	n/a
Free Cash Flow	-4.76M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -32155% and -25825%.

Gross Margin	100%
Operating Margin	-32155%
Pretax Margin	-25847.5%
Profit Margin	-25825%
EBITDA Margin	-31052.5%
EBIT Margin	-32155%
FCF Margin	-11895%

Dividends & Yields

BSGM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for BSGM is $10, which is 143.3% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10
Price Target Difference	143.3%
Analyst Consensus	Strong Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Feb 2, 2024. It was a backward split with a ratio of 1:10.

Last Split Date	Feb 2, 2024
Split Type	backward
Split Ratio	1:10

Scores

Altman Z-Score	-4.95
Piotroski F-Score	2

BioSig Technologies Inc. (BSGM)